Compound class:
Synthetic organic
Comment: JSF-3285 is an indazole antibacterial compound discovered using a structure-based approach to optimize DG167 (PubChem CID 70689295), a known inhibitor of Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase 1 (also known as β-ketoacyl-ACP synthase, KasA) [2]. JSF-3285 is being investigated as a preclinical candidate for the treatment of tuberculosis (TB). The structure is claimed in patent WO2019046467A1 filed by Rutgers University [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
4-fluoro-N-(3-methyl-1H-indazol-5-yl)butane-1-sulfonamide |
Database Links ![]() |
|
CAS Registry No. | 2293983-99-8 (source: Scifinder) |
ChEMBL Ligand | CHEMBL5181555 |
GtoPdb PubChem SID | 504705404 |
PubChem CID | 137523337 |
RCSB PDB Ligand | JFX |
Search Google for chemical match using the InChIKey | AHVAAGWAEHSRBU-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | AHVAAGWAEHSRBU |
UniChem Compound Search for chemical match using the InChIKey | AHVAAGWAEHSRBU-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | AHVAAGWAEHSRBU-UHFFFAOYSA-N |